Biotechnology

In a recent study posted to the medRxiv* preprint server, researchers evaluated the concurrent colonization of fungi in the nasopharynx of severe coronavirus disease 2019 (COVID-19) patients. They explored antifungal immunity pathways by analyzing...

INDIANAPOLIS and BLOOMINGTON, Ind. — A new study by Indiana University researchers has found that about 45% of patients who visit the emergency department for physical injuries and ailments also have mental health and...

Drug delivery technologies promise to create new treatments for cancer, heart disease, and other illnesses. More recently, the rapid development of nanoparticles for the COVID-19 mRNA vaccine has illustrated the power of nanotechnology in...

Osaka, Japan – Ischemic stroke, caused by a blockage of blood flow to the brain, is a common cause of death and disability. Treatments are urgently needed to improve patient outcomes, because recovery currently...

From MGIJun 15 2023 ​​​​​​SAN JOSE, United States, 14 June 2023 – Complete Genomics, Inc., a pioneering genomics company, today unveiled updated mission/vision statement to reflect renewed ambitions in taking on more for a better...

The first-ever State of the World’s Migratory Species report was launched today by the Convention on the Conservation of Migratory Species of Wild Animals (CMS), a UN biodiversity treaty, at the opening of a...

Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker...

Applied Cells is excited to announce the launch of its MARS® Ingenuity™ Reagent kits for fast and easy cell isolation. This innovative product line features both RUO and GMP-grade reagents, and has been specifically optimized for use on Applied...

The lightning-fast development of COVID-19 vaccines just months after the virus appeared was a triumph of modern science and saved millions of lives. But for all the good they did in reducing illnesses and...

Two decades after Craig M. Crews, PhD, successfully developed cancer therapies based on degrading unwanted or harmful proteins in cells, a six-year-old startup founded by the Yale University professor and serial entrepreneur is developing...